Results 131 to 140 of about 18,883,264 (389)
Molecular Oncology, EarlyView.This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu +12 more
wiley +1 more source
Molecular Oncology, EarlyView.This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci +6 more
wiley +1 more source
Journal of Medical Ethics and History of Medicine Contributors
Journal of Medical Ethics and History of Medicine, 2021 Journal of Medical Ethics & History of Medicine
doaj
Illustrations of the Botany and Other Branches of the Natural History of the Himalayan Mountains, and of the Flora of Cashmere [PDF]
John Forbes Royle
openalex +1 more source
Dolbear's Art of ProjectingThe Art of Projecting. A Manual of Experimentation in Physics, Chemistry, and Natural History with the Porte Lumiere and Magic Lantern.A. E. Dolbear [PDF]
, 1877 openalex +1 more source
Landscape of BRAF transcript variants in human cancer
Molecular Oncology, EarlyView.We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda +5 more
wiley +1 more source
History of Circumcision from the Earliest Times to the Present. P. C. Remondino [PDF]
, 1892 openalex +1 more source